Exalenz Bioscience Ltd Share Price
Equities
EXEN
IL0011048688
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- ILa | -.--% | +1.39% | +107.88% |
Sales 2018 | 13.14M 3.47M 1.31B 277M | Sales 2019 | 14.04M 3.71M 1.4B 296M | Capitalization | 77.67M 20.52M 7.77B 1.64B |
---|---|---|---|---|---|
Net income 2018 | -5M -1.32M -500M -105M | Net income 2019 | -1M -264K -100M -21.09M | EV / Sales 2018 | 15.2 x |
Net Debt 2018 | 2.93M 773K 293M 61.73M | Net Debt 2019 | 3.09M 817K 309M 65.23M | EV / Sales 2019 | 5.75 x |
P/E ratio 2018 |
-34.6
x | P/E ratio 2019 |
-40
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 24.36% |
Managers | Title | Age | Since |
---|---|---|---|
Raffi Werner
CEO | Chief Executive Officer | 65 | 30/09/10 |
Moshe Dori
DFI | Director of Finance/CFO | - | 28/01/19 |
Eitan Blank
COO | Chief Operating Officer | 53 | 31/12/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Kochan
BRD | Director/Board Member | 55 | 03/07/16 |
Moshe Arkin
BRD | Director/Board Member | 69 | 31/12/05 |
Hanna Lerman
BRD | Director/Board Member | 51 | 15/04/15 |
1st Jan change | Capi. | |
---|---|---|
+107.88% | 45.97M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- EXEN Stock